GOURLAY STEVE (Chief Medical Officer) reported 1 transaction at PRINCIPIA BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/20/2018ACC: 0001209191-18-051831
Officer· Chief Medical Officer
Since Sep 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
7.27K acquired · 7.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.27K
Price / share
—
Trade value
—
% of position
7.2%
9/18/2018
100.59K→107.86K
Total
Net shares
+7.27K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2018 | C · Conversion | +7.27K | — | — | 7.2% | 100.59K | 107.86K |
| Total | +7.27K | $0.00 | ||||||
Derivative Transactions1
Series B-3 Preferred Stock
Direct
Converts to
Common Stock
7.27K shares
Shares
−7.27K
Strike price
Held after
0.00
Exercisable
—
9/18/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B-3 Preferred Stock Direct | Common Stock7.27K shares | 9/18/2018 | C · Conversion | −7.27K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Warrant (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
625.00
Shares owned
625.00
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
625.00
Owned
625.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant (Right to Buy) Direct | Common Stock | — | — | 625.00 | 625.00 | |
| Total | 625.00 | 625.00 | ||||